Targeting Methylglyoxal in Diabetic Kidney Disease Using the Mitochondria-Targeted Compound MitoGamide

Diabetic kidney disease (DKD) remains the number one cause of end-stage renal disease in the western world. In experimental diabetes, mitochondrial dysfunction in the kidney precedes the development of DKD. Reactive 1,2-dicarbonyl compounds, such as methylglyoxal, are generated from sugars both endo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nutrients
Main Authors: Tan, Sih Min, Lindblom, Runa S. J., Ziemann, Mark, Laskowski, Adrienne, Granata, Cesare, Snelson, Matthew, Thallas-Bonke, Vicki, El-Osta, Assam, Baeza-Garza, Carlos D., Caldwell, Stuart T., Hartley, Richard C., Krieg, Thomas, Cooper, Mark E., Murphy, Michael P., Coughlan, Melinda T.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8145135/
https://ncbi.nlm.nih.gov/pubmed/33922959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/nu13051457
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados